Dr Jorg Taubel attending ACCP in San Diego

Posted:

September 2017

Dr Jorg Taubel will be attending the ACCP in San Diego, September 17-19, where he will be discussing his latest poster publications ‘The 24 Hour Profile of Moxifloxacin Effect on QTc – A Reflection of Diurnal Variations'

Back to news

More about us Adaptive Phase I, II & III Bridging Studies TQT Studies Patient Recruitment

Meet the experts

Richmond Pharmacology has a team of experts with extensive knowledge of clinical research trials.

Latest Publications

View our latest peer-reviewed publications from a selection of our clinical trials.

Latest Videos

Learn more about Richmond Pharmacology by viewing some of our videos.

Latest news

Upcoming Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

21 - 23 September 2020

Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.

View event

Richmond Pharmacology is delighted to confirm partnership with Intellia Therapeutics

October 20, 2020

Phase I study of Intellia Therapeutic’s NTLA-2001 for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN)

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020

ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

August 17, 2020

Richmond Pharmacology early phase drug development update.